- Home
- BMY vs ITUB Comparison
BMY vs ITUB Comparison
Compare BMY & ITUB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMY
- ITUB
- Stock Information
- Founded
- BMY 1887
- ITUB 1924
- Country
- BMY United States
- ITUB Brazil
- Employees
- BMY N/A
- ITUB N/A
- Industry
- BMY Biotechnology: Pharmaceutical Preparations
- ITUB Major Banks
- Sector
- BMY Health Care
- ITUB Finance
- Exchange
- BMY Nasdaq
- ITUB Nasdaq
- Market Cap
- BMY 95.0B
- ITUB 81.3B
- IPO Year
- BMY N/A
- ITUB N/A
- Fundamental
- Price
- BMY $47.23
- ITUB $7.56
- Analyst Decision
- BMY Hold
- ITUB Buy
- Analyst Count
- BMY 11
- ITUB 2
- Target Price
- BMY $55.64
- ITUB $6.18
- AVG Volume (30 Days)
- BMY 16.4M
- ITUB 20.2M
- Earning Date
- BMY 10-30-2025
- ITUB 11-04-2025
- Dividend Yield
- BMY 5.27%
- ITUB 5.66%
- EPS Growth
- BMY N/A
- ITUB 13.27
- EPS
- BMY 2.97
- ITUB 0.77
- Revenue
- BMY $48,034,000,000.00
- ITUB $25,400,232,630.00
- Revenue This Year
- BMY N/A
- ITUB $39.44
- Revenue Next Year
- BMY N/A
- ITUB $6.73
- P/E Ratio
- BMY $15.84
- ITUB $9.81
- Revenue Growth
- BMY 1.26
- ITUB N/A
- 52 Week Low
- BMY $42.52
- ITUB $4.42
- 52 Week High
- BMY $63.33
- ITUB $7.86
- Technical
- Relative Strength Index (RSI)
- BMY 57.46
- ITUB 58.01
- Support Level
- BMY $46.12
- ITUB $7.57
- Resistance Level
- BMY $49.99
- ITUB $7.86
- Average True Range (ATR)
- BMY 1.29
- ITUB 0.13
- MACD
- BMY 0.15
- ITUB 0.00
- Stochastic Oscillator
- BMY 60.49
- ITUB 46.49
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About ITUB Itau Unibanco Banco Holding SA (Each repstg 500 Preferred shares)
Itaú Unibanco is the largest privately held bank in Brazil, the result of the 2008 merger between Banco Itaú and Unibanco. In addition to Brazil, the bank has significant operations in Chile, Colombia, Argentina, Uruguay, and Paraguay. Itaú's commercial and consumer loans account for 35% and 43% of the bank's total loans, respectively, while foreign loans account for 22% of its portfolio. The bank also operates the fifth-largest insurer in Brazil and is the second-largest asset manager in the country, giving it broad reach over the Brazilian financial system.